The US Commercial organization, which is in the Global Hospital & Biosimilars organization, is comprised of over 200 products, spanning more than 10 therapeutic areas, with annual revenue of over $2.5B. The Biosimilars Analytics and Provider Contracting role has responsibility for provider contract strategy and analytics for the combined Inflammation & Immunology (I&I) and Oncology biosimilars (BSM) portfolios, with net revenue of ~$0.9B, within the US Commercial organization. This includes eight BSM assets - Abrilada, Inflectra, Nivestym, Nyvepria, Retacrit, Ruxience, Trazimera, Zirabev. The Biosimilars Analytics and Provider Contracting role will report to the US Commercial Pricing and Commercial Operations Lead. The Biosimilars Provider Contracting role is focused on provider contract strategy and analytics for our Biosimilars portfolio. This role will be responsible for modeling, analytics and forecasting buy and bill contracting models and being the steward of brand economics across managed markets, hospital systems, GPO customer segments and key accounts. This role works closely with the Biosimilars Portfolio team and other cross-functional partners to support biosimilar portfolio objectives through transactional provider contracting and pricing analytics support .
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level